A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2011
11/09/2011	CN101698094B Distillate for treating white vein diseases and preparation method thereof
11/09/2011	CN101658485B Nanometer hybridized hydrogel with durable broad spectrum antibacterial performance and preparation method thereof
11/09/2011	CN101637450B Levocarnitine liposomes injection and its preparation method
11/09/2011	CN101632754B Chinese medicinal composition for treating pharyngitis and preparation method thereof
11/09/2011	CN101623256B Ivermectin nanoemulsion drug combination and preparation method thereof
11/09/2011	CN101618018B Miconazole nitrate particle, and preparation method and medicinal composition thereof
11/09/2011	CN101584703B Pharmaceutical composition for treating colpitis and preparation method thereof
11/09/2011	CN101579495B Application of Chinese medicine composite in preparation of medicine for treating chronic gastritis
11/09/2011	CN101579329B Bevantolol hydrochloride sustained release preparation
11/09/2011	CN101559156B Application of traditional Chinese medicine composition in preparing medicament for curing chronic inflammatory demyelinating polyneuropathy
11/09/2011	CN101536982B Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof
11/09/2011	CN101507710B Safe selenium-complement sustained-release microspheres and preparation method thereof
11/09/2011	CN101502621B Nutrient solution for cleaning blood and softening blood vessel
11/09/2011	CN101502510B Medicament composition for treating colpitis symptoms and preparation method thereof
11/09/2011	CN101495094B Osmotic delivery systems and piston assemblies
11/09/2011	CN101485690B Method for producing Chinese medicine tablets
11/09/2011	CN101455645B Preparation method of medicine microspheres using plant soy protein as carrier
11/09/2011	CN101420982B Dry direct compression fast disintegrating tablet
11/09/2011	CN101406680B Compound syrup paste for epilepsy
11/09/2011	CN101406613B Use of Chinese medicinal composition in preparing medicament for treating vital myocarditis
11/09/2011	CN101396560B Medicine composition for treating polycystic kidney disease and use thereof
11/09/2011	CN101396521B Use of traditional Chinese medicine composition in preparing medicine for treating cerebral circulation insufficiency
11/09/2011	CN101390844B Arginine ibuprofen tablet and preparation method thereof
11/09/2011	CN101371842B Lornoxicam microsphere and preparation method thereof
11/09/2011	CN101365449B Nanoparticulate benzothiophene formulations
11/09/2011	CN101352497B Chinese medicinal composition for removing chloasma, and preparation method and uses thereof
11/09/2011	CN101342280B Chinese medicine externally used paste for curing bronchial asthma and preparation method thereof
11/09/2011	CN101301417B Powder for treating circumscribed external otitis
11/09/2011	CN101278932B Sustained release medicinal compositions containing Zaltoprofen, preparation method and application thereof
11/09/2011	CN101237860B Particles having hydrophobic material therein
11/09/2011	CN101224251B Chinese prepared medicine for treating chronic gastritis
11/09/2011	CN101185708B Powder agent medicine for treating acute otitis media suppurative
11/09/2011	CN101176757B Pomegranate leaf extract preparations
11/09/2011	CN101164599B Medicine, health-care product and cosmetics composition for treating chloasma
11/09/2011	CN101143145B Tadalafil chewing gum and manufacturing method and application
11/09/2011	CN101112408B Sustained-release ji chrysanthemum tablet and method for preparing the same
11/09/2011	CN101032683B Xanthin micro-capsule and the preparing method
11/09/2011	CN101010099B Edible vaccine
11/08/2011	USRE42902 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use
11/08/2011	US8053626 Absorbent article containing a skincare composition and method of making and using same
11/08/2011	US8053599 Drug containing (2R)-2-propyloctanoic acid as the active ingredient
11/08/2011	US8053469 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions
11/08/2011	US8053429 Solid oral dosage form containing an enhancer
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053398 Polyalkylene glycol components with different molecular weights, a viscosity inducing component and a preservative; clear and substantially anhydrous; generating heat when placed in contact with water
11/08/2011	US8053000 Compositions for drug delivery
11/08/2011	US8052999 Granules, tablets and granulation
11/08/2011	US8052998 Mixture of biodegradable polymer and cationic polymer
11/08/2011	US8052997 Anti-bacterial composition and method for producing the same
11/08/2011	US8052996 Two-piece, internal-channel osmotic delivery system flow modulator
11/08/2011	US8052995 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	US8052994 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	US8052993 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
11/08/2011	US8052991 Unsaturated fatty acid is applied on a biologically inert matrix having a large surface area and is subsequently dried; foods, beverages
11/08/2011	US8052987 Intermittently administering a bisphosphonate to patient, wherein period between administrations of bisphosphonate is at least 6 months; treatment of osteoporosis
11/08/2011	US8052984 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
11/08/2011	US8052983 Administering a photosensitive, non-antibiotic tetracycline, preferably chosen from CMT-1 through CMT-10, without administering a bisphosphonate compound; side effect reduction
11/08/2011	US8052982 Bioimplant formulation comprising lecithin and stearin
11/08/2011	US8052981 Mono- and disaccharide derivatives
11/08/2011	US8052076 Particle-size reduction apparatus, and use thereof
11/08/2011	CA2702431C Ready-to-use bivalirudin compositions
11/08/2011	CA2631233C Ganaxolone formulations and methods for the making and use thereof
11/08/2011	CA2594215C Sustained-release nanoparticle compositions and methods for using the same
11/08/2011	CA2569674C Sublingual buccal effervescent
11/08/2011	CA2556624C Abuse resistance opioid transdermal delivery device
11/08/2011	CA2526208C Infusion preparation for peripheral parenteral administration and method for stabilizing vitamin b1
11/08/2011	CA2522292C Nasal pharmaceutical formulations and methods of using the same
11/08/2011	CA2512015C Topical stabilized prostaglandin e compound dosage forms
11/08/2011	CA2493983C Multicomponent pharmaceutical dosage form
11/08/2011	CA2476054C Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
11/08/2011	CA2470396C Methods for preserving ophthalmic solutions and preserved ophthalmic solutions
11/08/2011	CA2466321C Gel comprising at least a retinoid and benzoyl peroxide
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2451552C Topical application of thiazolylamides
11/08/2011	CA2442539C Method and composition for solubilising a biologically active compound with low water solubility
11/08/2011	CA2422346C Dialysate of peritoneal dialysis and its preparation method
11/08/2011	CA2413698C Endoparasiticidal agents for voluntary oral ingestion by animals
11/08/2011	CA2399100C Purified lh
11/04/2011	CA2758029A1 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
11/03/2011	WO2011137459A1 Dosage forms of elinogrel and methods of injectable administration thereof
11/03/2011	WO2011137456A2 Methods and mechanisms involving hyperpigmentation particularly for african american skin
11/03/2011	WO2011137292A2 Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering
11/03/2011	WO2011137228A2 Composition and method for treating eustachian tube dysfunction
11/03/2011	WO2011136754A1 A medicament developed for the treatment of respiratory diseases
11/03/2011	WO2011136752A1 Combined pharmaceutical composition comprising carmoterol and ciclesonide for the treatment of respiratory diseases
11/03/2011	WO2011136751A2 Water soluble pharmaceutical composition
11/03/2011	WO2011136750A1 Pharmaceutical compositions inducing synergistic effect
11/03/2011	WO2011136691A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases
11/03/2011	WO2011136376A1 Enteric tablet
11/03/2011	WO2011136373A1 Enteric tablet
11/03/2011	WO2011136369A1 Cationic lipid
11/03/2011	WO2011136336A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract
11/03/2011	WO2011136288A1 Transdermally absorbable donepezil-containing preparation
11/03/2011	WO2011136283A1 Skin irritation suppressant and transdermal preparation
11/03/2011	WO2011135905A1 Lipid membrane structure
11/03/2011	WO2011135585A2 Aqueous pharmaceutical solution of ciclesonide
11/03/2011	WO2011135582A2 Pharmaceutical compositions of dronedarone
11/03/2011	WO2011135581A2 Pharmaceutical compositions of dronedarone
11/03/2011	WO2011135580A2 Pharmaceutical compositions of sirolimus
11/03/2011	WO2011135461A2 Clay compositions

1 ... 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 ... 2991